✨ Free AI Report
Amphastar Pharmaceuticals, Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Amphastar Pharmaceuticals, Inc.
Company Research

Amphastar Pharmaceuticals, Inc.: Business Overview, Financials & Competitive Analysis

Amphastar Pharmaceuticals, Inc. is a renowned biopharmaceutical company focused on developing, manufacturing, and marketing generic and proprietary injectable and inhalation products. Established in...

Analyst-debate audio for Amphastar Pharmaceuticals, Inc.

AskCyborg analysts argue the bull and bear cases for Amphastar Pharmaceuticals, Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Company Overview of Amphastar Pharmaceuticals, Inc.Product PortfolioAmphastar Pharmaceuticals, Inc. Leadership and Management TeamFinancial Overview of Amphastar Pharmaceuticals, Inc.Marketing StrategiesMarket Overview and Competitors
Get Interactive Report Freeor start reading below
Live on AskCyborg
5/10Mixed
Amphastar Pharmaceuticals, Inc.

Amphastar is a transitional story with asymmetric risk-reward: strong long-term pipeline potential offset by near-term headwinds in core franchises.

▶︎ Listen to the 90-second analyst debate
5/ 10Mixed

Cyborg Score thesis

Amphastar is a transitional story with asymmetric risk-reward: strong long-term pipeline potential offset by near-term headwinds...

Read the full analyst-debate transcript →
Industry Specialty Pharmaceuticals / Complex Generics and Proprietary Injectables
3 named competitors
4 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: August 17, 2026
AI-Verified Research
30+ Page Report

Get the Latest Amphastar Pharmaceuticals, Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Amphastar Pharmaceuticals, Inc. is a renowned biopharmaceutical company focused on developing, manufacturing, and marketing generic and proprietary injectable and inhalation products. Established in 1996 and headquartered in Rancho Cucamonga, California, Amphastar has carved a niche for itself in the pharmaceutical industry through its innovative products and commitment to quality.

Amphastar Pharmaceuticals, Inc. Research Report delves deeply into the company’s operations, providing a comprehensive overview of its product portfolio, leadership team, financial status, marketing strategies, market overview and competitors, sales strategies, technological advancements, HR practices, corporate responsibility initiatives, and future plans.

Company Overview of Amphastar Pharmaceuticals, Inc.

Pro stress-test →

Amphastar Pharmaceuticals, Inc. specializes in the development, production, and marketing of human prescription pharmaceuticals and animal health-related products. With a focus on generic and proprietary injectable and inhalation products, the company has a diverse range of offerings that cater to various medical needs.

Product Portfolio

Pro stress-test →

Amphastar’s product portfolio includes a wide array of injectable and inhalation therapies. Some of their notable products include:

  • Primatene Mist: An over-the-counter inhalation product for the temporary relief of mild symptoms of intermittent asthma.
  • Adrenalin: A life-saving injectable product used for various medical emergencies, including cardiac arrest and severe allergic reactions.
  • Enoxaparin Sodium Injection: A generic version of a low molecular weight heparin used to prevent and treat blood clots.

These products highlight Amphastar’s commitment to addressing critical health needs through innovative solutions.

Amphastar Pharmaceuticals, Inc. Leadership and Management Team

Pro stress-test →

The leadership team at Amphastar is composed of experienced professionals with a profound understanding of the pharmaceutical industry:

  • Dr. Jack Y. Zhang – Chairman, CEO, and Co-Founder: With a Ph.D. in Chemistry, Dr. Zhang has been instrumental in guiding the company’s strategic direction.
  • Dr. Xiaochuan “Charlie” Zhang – President and Co-Founder: Dr. Zhang’s expertise in pharmaceutical development and manufacturing has been vital to the company’s growth.
  • William J. Peters – Chief Financial Officer: With extensive experience in finance, Peters oversees the company’s financial operations.

Financial Overview of Amphastar Pharmaceuticals, Inc.

Amphastar has shown steady financial growth over the years. Key financial metrics include:

  • Revenue: The company has consistently increased its revenue through strategic product launches and market expansion.
  • Net Income: Amphastar has maintained a healthy net income, reflecting its efficient operations and cost management.
  • R&D Investment: Significant investment in research and development underscores the company’s commitment to innovation.

Marketing Strategies

Amphastar employs a multi-faceted marketing approach to reach its target audience:

  • Direct Sales: The company has a dedicated sales force that works directly with healthcare providers and institutions.
  • Digital Marketing: Leveraging digital platforms to enhance brand visibility and engage with consumers.
  • Trade Shows and Conferences: Active participation in industry events to showcase their products and connect with stakeholders.

Market Overview and Competitors

The pharmaceutical market is highly competitive, with several key players:

  • Pfizer Inc.
  • Sanofi
  • Teva Pharmaceutical Industries Ltd.

Amphastar’s focus on niche markets and innovative products helps it stand out in this competitive landscape.

Sales Strategies

To drive sales, Amphastar utilizes various channels:

  • Wholesale Distribution: Partnering with major wholesalers to ensure widespread product availability.
  • Retail Pharmacies: Ensuring their products are available in retail pharmacy chains.
  • Direct Sales to Hospitals: Engaging directly with hospitals and healthcare providers for bulk purchases.

Technologies Utilized

Amphastar leverages advanced technologies to enhance its product offerings:

  • Advanced Manufacturing Techniques: Ensuring high-quality production standards.
  • Innovative R&D Labs: Continuously developing new and improved pharmaceutical products.

HR Practices

Amphastar places a strong emphasis on its human resources practices:

  • Employee Development: Offering continuous training and development programs.
  • Diverse and Inclusive Workplace: Promoting a culture of diversity and inclusion.
  • Competitive Benefits: Providing comprehensive benefits to employees.

Corporate Responsibility

Amphastar is committed to corporate social responsibility (CSR) initiatives:

  • Environmental Sustainability: Implementing eco-friendly practices in their operations.
  • Community Engagement: Actively participating in community support and development programs.

Future Plans

Looking ahead, Amphastar aims to:

  • Expand Product Portfolio: Introducing new products to address unmet medical needs.
  • Global Expansion: Exploring new markets to extend their reach.
  • Enhanced R&D: Continuing to invest in research and development for groundbreaking innovations.

Our detailed report on Amphastar Pharmaceuticals, Inc. offers an in-depth analysis of all these aspects and more, providing valuable insights for investors, stakeholders, and industry enthusiasts.


Get the full report on Amphastar Pharmaceuticals, Inc. by subscribing

What the analysts stress-tested

The top findings that survived the multi-agent debate for Amphastar Pharmaceuticals, Inc..

+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

Get alerted when Amphastar Pharmaceuticals, Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Glucagon genericsCompetitive generic pressure on Amphastar's legacy productsEpinephrine/Naloxone genericsLong-established competition in emergency injectable spaceBAQSIMI direct competitorProprietary glucagon alternative for diabetes management

Compare Amphastar Pharmaceuticals, Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Amphastar Pharmaceuticals, Inc. operates in Specialty Pharmaceuticals / Complex Generics and Proprietary Injectables. See how the rest of the sector scores on the Cyborg framework.

Browse Specialty Pharmaceuticals / Complex Generics and Proprietary Injectables research →
NEW · MCP server

Ask your AI assistant about Amphastar Pharmaceuticals, Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Amphastar Pharmaceuticals, Inc. and its top competitor on Cyborg Score”
“What did Amphastar Pharmaceuticals, Inc. do this quarter?”
“Is Amphastar Pharmaceuticals, Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Amphastar Pharmaceuticals, Inc. do?+
Amphastar Pharmaceuticals, Inc. is a renowned biopharmaceutical company focused on developing, manufacturing, and marketing generic and proprietary injectable and inhalation products. Established in...
What is Amphastar Pharmaceuticals, Inc.'s Cyborg Score?+
Amphastar Pharmaceuticals, Inc. has a Cyborg Score of 5/10 (Mixed). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Amphastar Pharmaceuticals, Inc.'s main competitors?+
Named competitors include Glucagon generics, Epinephrine/Naloxone generics, BAQSIMI direct competitor. The full competitive landscape is in the AskCyborg report.
How can I get the full Amphastar Pharmaceuticals, Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Amphastar Pharmaceuticals, Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Amphastar Pharmaceuticals, Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

More Company Research

Ai Infrastructure Systems Industry BriefingPet Insurance Industry BriefingSelf-Storage Industry BriefingMetal Additive Manufacturing Industry BriefingAi Accelerator Hardware Systems Industry BriefingLuxury Wines & Spirits Industry BriefingEnzymatic Plastic Recycling Industry BriefingInfrastructure as a Service (IaaS) Industry Briefingluxury fashion apparel Industry BriefingPremium Consumer Smartphones And Integrated Ecosystem Services Industry BriefingMulti Cloud Management Industry BriefingCloud Based Omnichannel Fulfillment And Logistics Industry Briefing

Explore Industry Research

Travel Insurance Industry Company Research ReportSecurity Services Industry Company Research ReportLandscaping and Grounds Maintenance Industry Company Research ReportJanitorial and Cleaning Services Industry Company Research ReportSustainability Consulting Industry Company Research ReportReal Estate Investment Trusts (REITs) Industry Company Research Report
Browse All Company ResearchBrowse All Industry ResearchRSS Feed